This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Indian healthcare providers and pharmacompanies pace up their efforts with early detection and research for new medicines to combat the spread of tuberculosis as drug resistance concerns emerge. TB is a significant public health threat, with an estimated 10 million annual cases. India shares the highest TB burden with 2.69
The Drugs Technical Advisory Board (DTAB) has suggested to the ministry of health and family welfare (MoHFW) to write to the ministry of corporate affairs to mandate the pharmacompanies to spend almost one per cent of their net profit for providing free medicines in medicine banks as part of the Corporate Social Responsibility (CSR). […]
The pharmacompanies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.
Severino left the pharmacompany in April after eight years as its chief scientist and then president. He'll lead Tessera Therapeutics, a well-funded genetic medicine startup.
The Swiss pharmacompany is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.
London, ATMPS Ltd/Hataali – the leader in blockchain-based data sharing platforms for advanced therapies – announces it has been granted a patent from the United States Patent and Trademark Office (USPTO) for the use of blockchain technologies in personalised medicines.
Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharmacompanies must prevent the increased erosion of profit margins. For example, AstraZeneca is automating the enter design-make-test-analyse cycle for drug discovery in its Swedish iLab. Remote-controlled robotic labs.
Recent cases in the pharmaceutical sector include Poolbeg Pharma finding more than one respiratory syncytial virus (RSV) vaccine candidate with AI by going through a vast amount of early stage clinical data to prioritise candidates and reposition them as novel treatments for RSV infection.
Collaborative partnerships between universities and pharmaceutical companies are crucial for advancing biomedical research and development (R&D) and creating groundbreaking medicines. Explore the benefits and significance of these alliances in this informative piece.
EHDS is the first data space devised to promote health-data exchange and support research on new treatments, preventative strategies, medicines, and medical devices while aiming to allow individuals the right to control their personal health data. The post The largest pharmacompany in Europe calls for interoperability appeared first on.
Jupiter Neurosciences, a clinical-stage pharmacompany specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00
On March 30, ViiV Healthcare and Medicines Patent Pool (MPP), announced sublicensing agreements with the pharma manufacturers Aurobindo , Cipla and Viatris to produce generic forms of the long-acting cabotegravir used as pre-exposure prophylaxis (PrEP) for HIV.
The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharmacompanies for their efforts to improve delivery of medicines to lower income countries – sees GSK retain the number one position, newly joined by Johnson & Johnson in second and AstraZeneca in third. Jayasree Iyer.
Companies can also support pre-existing SDOH research initiatives. Then of course, there is the heart of the matter—developing new medicines for diseases that disproportionately affect disadvantaged communities. Studies should include as detailed SDOH data as possible. EVERSANA INTOUCH clients have done all of these things, and more.
Jazz Pharmaceuticals has broken ground on a new $100 million manufacturing plant for cannabis-based medicines in the UK. According to a press release from Jazz Pharma, the plant has a planned opening date in 2024 and will welcome 100 new employees. Jazz acquired GW to beef up its neuroscience program and add a cannabis pipeline.
Precision and personalised medicine has a significant impact on how pharmacompanies and other stakeholders engage with patients, providing treatments that better fit specific patient populations, rather than generating inconsistent results in a broader patient population.
But it has also faced criticism from pharmacompanies that say it undervalues medicines – patients in the country were denied access to the expensive cystic fibrosis drug Orkambi for four years because of a pricing row with NICE and the NHS.
However, some of the key pharmacompanies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.
A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.
The US Senate has come together to pass a bill that aims to prevent pharmacompanies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.Lawmakers unanimously passed the Affordable Prescriptions for Patients Act of 2023 (S-150), which is part of a lengthening list of measures being taken by Congress to curb the (..)
According to a team of Penn State College of Medicine researchers, care for the 15 most prevalent types of cancer in the U.S. The FDA says it has used innovative research shortcuts to speed up the availability of medicines for desperately ill patients. National costs for cancer care were estimated to be $190.2 population.
Consumer and health organisations in the UK have written to the Trade Secretary Kemi Badenoch, saying a leaked chapter of the proposed UK-India free trade agreement (FTA) could raise the price of medicines used by the NHS. “India…supplies our NHS with 25% of all the medicines used to treat patients here in the UK,” they continue.
The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharmacompanies.
Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. Precision medicine is emerging as a key approach for disease treatment and prevention, which makes it even more critical to get the right medicine to the right patients. C-suite taking notice.
anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. Pharmacompanies have very little control over patients’ prices for their Rxs. A federal appeals court rejected Pfizer’s challenge to a U.S.
Pharmacompanies such as Calliditas Therapeutics AB, Chinook Therapeutics, Inc., Further, the IgAN patient pool is huge and the prevalence is expected to increase in the coming next years that will further attract the pharma and biotech companies to work in the domain. million in 2020 in the 7MM. .
J&J did the right thing by asking for help from other pharmacompanies, but as I thought, COVID vaccines are a huge source of income, not helping the public defeat this pandemic. In the US, we practice medicine to prevent litigation, and ordering tests is a way to ensure all the bases are covered.
Only a limited number of international pharmacompanies, however, operate manufacturing sites in the country. Large Brazilian pharmacompanies already play a major role in distributing Covid-19 vaccines to all of Latin America. French and Italian manufacturers have two companies in Brazil.
Clinical-stage pharmacompany, PharmaKure which develops precision medicine for Alzheimerâs Disease and other neurological diseases has announced a collaboration agreement with one of the largest comprehensive universities in Malaysia.
The European Medicines Agency (EMA) has produced similar recommendations, but with a focus on using RFID tags to track the movement of drugs through the supply chain, and instructed companies to implement appropriate security measures to protect patient privacy and prevent counterfeiting.
This is where partners such as Abacus MedicinePharma Services can really help,” says Simon Estcourt, managing director of Abacus MedicinePharma Services. There are many reasons why a company might prefer to keep commercialisation activities inhouse. De-risking drug launch.
Much is being said about integrated messaging in the CPG arena, but in pharma, the messages to the patient and physician are often different when there should be some overlap. Most physicians are trained in medicine and rely on their experiences to understand patients. An integrated approach that ensures a consistency of message(s).
The UK government has asked pharmacompanies to build a six-week stockpile of drugs and find alternative shipping routes to the congested Dover-Calais crossing as the country heads for Brexit at the end of the year.
Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.
This drug was never about patients; it was about a company whose ego got too big and needed a savior in the form of a medicine that could bring in hundreds of millions of dollars. Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place. He has zero credibility with the HCP community.
This strategic move transformed Actavis into one of the largest pharmacompanies globally, with a strong presence across branded, generic and over-the-counter (OTC) medicines. The integration of Shire strengthened Takedas R&D pipeline, increasing its focus on innovative medicines and transformative therapies.
” J&J has had problems in the past, but they’re trying to be an ethical and responsible pharmacompany. It’s going to continue until we put politics aside and say “enough.” PBMs too are making a fortune.
consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. consumers say they trust pharmacompanies more than they did before the COVID-19 pandemic, according to Accenture’s 2021 survey. What does this mean for DTC and HCP marketing?
Supossidly Good Rx has “relationships” with most top pharmacompanies, but that relationship may be to say “hello.” Do you want your employer, or your insurance company, or anyone else to know you’re on anti-depressants, HIV medication, Viagra, or that you regularly get medicine for genital warts?
A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.
Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). Experts across the board are predicting demand for antiviral drugs will rapidly outpace supply. spending annually. ” More checks from PhRMA to politicians are coming up.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content